Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma

Bumma, N., Richter, J., Jagannath, S., Lee, H. C., Hoffman, J. E., Suvannasankha, A., Zonder, J. A., Shah, M. R., Lentzsch, S., Baz, R., Maly, J. J., Namburi, S., Pianko, M. J., Ye, J. C., Wu, K. L., Silbermann, R., Min, C.-K., Vekemans, M.-C., Munder, M., … Dhodapkar, M. V. (2024). Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma. Journal of Clinical Oncology, 42(22), 2702–2712. https://doi.org/10.1200/jco.24.01008
Authors:
Naresh Bumma
Joshua Richter
Sundar Jagannath
Hans C. Lee
James E. Hoffman
Attaya Suvannasankha
Jeffrey A. Zonder
Mansi Shah
Suzanne Lentzsch
Rachid Baz
Joseph Maly
Swathi Namburi
Matthew J. Pianko
Jing Christine Ye
Ka Lung Wu
Rebecca Silbermann
Chang‐Ki Min
Marie‐Christiane Vekemans
Markus Munder
Ja Min Byun
Joaquín Martínez‐López
Kaniel Cassady
Michelle DeVeaux
Dhruti Chokshi
Anita Boyapati
Anasuya Hazra
George D. Yancopoulos
L. Andres Sirulnik
Karen Rodriguez Lorenc
Glenn Kroog
Yariv Houvras
Madhav V. Dhodapkar
Affiliated Authors:
Suzanne Lentzsch
Columbia Affiliation:
Subjects:
Multiple Myeloma (MeSH)
Antibodies, Bispecific (MeSH)
Diagnosis and Treatment of Multiple Myeloma (OpenAlex Topic)
Chimeric Antigen Receptor T Cell Therapy (OpenAlex Topic)
Therapeutic Antibodies: Development, Engineering, and Applications (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1200/jco.24.01008
PMID:
38879802
DOI:
10.1200/jco.24.01008
Journal:
Journal of Clinical Oncology
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: